Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation

Liver Transplantation

Volumn 12, Issue 2, 2006, Pages 226-230

  Mangus, Richard S ^a   Tector, A Joseph ^a   Agarwal, Avinash ^a   Vianna, Rodrigo ^a   Murdock, Phillip ^b   Fridell, Jonathan A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana Organ Procurement Organization   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HTK SOLUTION; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE COST; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER PRESERVATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONALCOHOLIC FATTY LIVER; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTIDINE; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRYPTOPHAN;

EID: 33244466502     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20552     Document Type: Article

References (14)

1. Bretschneider JH. Myocardial protection. Thorac Cardiovasc Surg 1980;1980:285.
2. Gubernatis G, Pichlmayr R, Lamesch P, Grosse H, Bornscheuer A, Meyer H, et al. HTK-solution (Bretschneider) for human liver transplantation: first clinical experiences. Langenbecks Arch Chir 1990;375:66-70.
3. Hatano E, Kiuchi T, Tanaka A, Shinohara H, Kitai T, Satoh S, et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Lond) 1997;93:81.
4. Erhard J, Lange R, Scherer R, Kox WJ, Bretshneider HJ, Gebhard MM, Eigler FW. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation: a prospective, randomized study. Transpl Int 1994;7:177-181.
5. Fridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and university of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004;77:1304-1306.
6. Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate (HTK) solution and University of Wisconsin (UW) solution with pulsatile perfusion in clinical kidney transplantation. Transpl Proc 2005;37(5):2016-2019.
7. de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999;12:447.
8. Potdar S, Malek S, Eghtesad B, Shapiro R, Basu A, Patel K, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004;18:661-665.
9. Isemer FE, Ludwig A, Schunck O, Bretschneider JH, Peiper HJ. Kidney procurement with the HTK solution of Bretschneider. Transplant Proc 1988;20:885-886.
10. Lange R, Erhard J, Rauen U, de Groot H, Eigler FW. Hepatocellular injury during preservation of human livers with UW and HTK solution. Transplant Proc 1997;29:400-402.
11. Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University of Wisconsin preservation solutions in transplantation. Int Surg 2003; 88:145-151.
12. Pokorny H, Rasoul-Rockenschaub S, Langer F, Windhager F, Rosensting A, Lange R. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation: a prospective multi-centre observation study. Transplant Int 2004;17:256.
13. Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004;10:1415-1421.
14. Testa G, Malago M, Nadalin S, Treptow B, Paul A, Frilling A, Broelsch CE. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl 2003;9:8222-8226.